Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04874610 · ClinicalTrials.gov registry record
Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 15
- Enrollment target
NCT04874610: Completed study, sponsored by Duke University.
NCT04874610 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04874610 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Single center, open-label, non-randomized study to assess the pharmacokinetic profile of methylprednisolone in healthy children 2-20 years of age admitted for asthma exacerbation.
Primary Outcome
Prednisolone levels at steady state concentration
Interventions
- DRUG Methylprednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2022-03-31 |
What the finished NCT04874610 record still lists
NCT04874610 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04874610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04874610 about?
NCT04874610 is a clinical study titled "Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus". Single center, open-label, non-randomized study to assess the pharmacokinetic profile of methylprednisolone in healthy children 2-20 years of age admitted for asthma exacerbation.
What is the current status of trial NCT04874610?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-08-16. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04874610?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04874610?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI